Lymphoblastic Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoblastic Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Expanded access program for venetoclax and navitoclax in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphom…
-
CLINICAL_TRIALS withdrawal · 2024-06-21Clinical Trial Update: HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]
Clinical trial update notes the withdrawal of a Phase 1/2 study evaluating decitabine with venetoclax and navitoclax for relapsed or refract…
-
CLINICAL_TRIALS withdrawal · 2015-05-13Clinical Trial Update: An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) [Phase 2]
Phase 2 open-label PK study of intramuscular Erwinaze (asparaginase Erwinia chrysanthemi) / Erwinase (crisantaspase) for acute lymphoblastic…